Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.
Nested Therapeutics has raised $90.0M in total funding. The most recent round was Series A. The last funding was announced in October 2022.
Nested Therapeutics's investors include Foresite Capital, Avidity Partners, Versant Ventures, S32, Goldman Sachs Asset Management.
Nested Therapeutics is headquartered in Cambridge, United States.
Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.
Nested Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nested Therapeutics — Funding & Investors." VCBacked, October 6, 2022, https://www.vcbacked.co/company/nested-therapeutics. Accessed August 16, 2026.
VCBacked. (2022). Nested Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/nested-therapeutics
{{cite web |title=Nested Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nested-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated